Total
0
Shares
Claritas Pharmaceuticals (TSX:KLY) forms Nitric Oxide Scientific Advisory Board
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Relay Medical (RELA) is retaining Emerging Markets Consulting to provide investor relations advisory services
  • Emerging Markets Consulting specializes in helping small and mid-sized public companies establish brand awareness
  • It also helps increase market share to its customer base while improving visibility to the institutional and retail investment community
  • Relay Medical is down 6.17 per cent on the day, with shares trading at C$0.38 at 3:44 pm ET

Relay Medical (RELA) is retaining Emerging Markets Consulting to provide investor relations advisory services.

Emerging Markets Consulting specializes in helping small and mid-sized public companies establish brand awareness and increase market share to its customer base while improving visibility to the institutional and retail investment community.

"With the recent deployments of Toronto Airport and partnering with Canada's largest lab company Lifelabs, Relay has a lot to share with the marketplace. We look forward to working with Emerging Markets to bring Relay to a broader audience and build on our communication as we progress through these milestones and others like the recent acquisition of Cybeats, an innovative IoT Cybersecurity company," said Relay Medical President W. Clark Kent.

"With the termotulous year we have all faced, hope springs eternal. Working with Relay Medical is an honor and a privilege. The company's prospects met our stringent requirements and we are happy to have Relay on our prestigious client roster," said EMC President James Painter.

Relay Medical is a Canadian-based technology innovation company focused on the development of novel technologies in the diagnostics and AI data science and IoT security sectors.

Relay Medical is down 6.17 per cent on the day, with shares trading at C$0.38 at 3:44 pm ET.

More From The Market Herald
Neovasc’s (TSX:NVCN) Reducer receives first national European reimbursement

" Neovasc (TSX:NVCN) announces FDA approval of clinical trial

Neovasc (NVCN) has received approval from the FDA for the Investigational Device Exemption regarding its COSIRA-II IDE Clinical Trial.
Relay Medical (CSE:RELA) & Fio to provide rapid COVID-19 testing at TIFF

" ScreenPro (CSE:SCRN) providing COVID-19 testing at TIFF

ScreenPro (SCRN) is providing COVID-19 testing services at this year’s Toronto International Film Festival.
Aurora Spine Corporation (TSXV:ASG) announces $6.5 million private placement

" Aurora Spine Corporation (TSXV:ASG) announces $6.5 million private placement

Aurora Spine Corporation (ASG) has announced a C$6.5 million private placement with institutional investors.
VitalHub (TSXV:VHI) signs multi-year contract with Hampshire Hospitals NHS Foundation Trust

" Skylight Health Group (TSXV:SLHG) acquires Pennsylvania Clinic Group

Skylight Health Group Inc. (SLHG) executes the definitive agreements to acquire a controlling interest in Aspire Health Concepts, Inc.